Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?

April 10, 2017 updated by: Mohammed Faris, Ain Shams University

Women planned to undergo blastocyst-stage embryo transfer after IVF/ICSI were randomized into 2 groups:

  • group I: women who had only good-quality embryo transfer.
  • group II: women who had both good-quality and poor-quality embryo transfer.

primary outcome was ongoing clinical pregnancy rate

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

627

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women undergoing primary IVF/ICSI cycles for tubal factor/unexplained infertility and had blastocyst-stage ET

Exclusion Criteria:

  • cleavage-stage ET.
  • women who had no good-quality embryos to transfer
  • women who had known poor endometrial receptivity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Good-quality embryo transfer
Women who had only good-quality embryo transfer
Transfer of different qualities of embryos at blastocyst stage
Active Comparator: good- and poor-quality embryo transfer
Women who had both good- and poor-quality embryo transfer
Transfer of different qualities of embryos at blastocyst stage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ongoing clinical pregnancy rate
Time Frame: 12 weeks
viable intrauterine pregnancy ongoing beyond 12 weeks of gestation
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemical pregnancy rate
Time Frame: 2 weeks after ET
positive serum hCG
2 weeks after ET
Clinical pregnancy rate
Time Frame: 4 weeks after ET
sonographic detection of viable intrauterine gestational sac
4 weeks after ET
Multiple pregnancy rate
Time Frame: 4-6 weeks after ET
No. of intrauterine gestational sacs
4-6 weeks after ET
Ectopic pregnancy rate
Time Frame: 6 weeks after ET
Extrauterine pregnancy
6 weeks after ET

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mohammed Faris, MD, Dar El Teb IVF and Infertility Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

March 1, 2017

Study Registration Dates

First Submitted

April 10, 2017

First Submitted That Met QC Criteria

April 10, 2017

First Posted (Actual)

April 13, 2017

Study Record Updates

Last Update Posted (Actual)

April 13, 2017

Last Update Submitted That Met QC Criteria

April 10, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DAT-055

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Embryo transfer

Subscribe